DealZone

Sanofi-Aventis is considering whether to raise its $18.5-billion bid for drugmaker Genzyme as soon as next week, Bloomberg said, citing sources. Sanofi has not ruled out a hostile bid but would prefer friendly negotiations, the report said. *View article *View factbox

India’s showpiece IT services companies are scouting for acquisitions in overseas markets as they focus on expanding geographical presence as well as client base to boost growth, Reuters reported from the India Investment Summit in Bangalore. *View article *Full coverage

Companies are flush with cash, financing is cheap and dealmaking has staged a comeback, according to Bloomberg’s third-quarter review of M&A activity. *View Bloomberg article

Want to start your own hedge fund? Vanity Fair offers its own five-step program. *View Vanity Fair article